344 related articles for article (PubMed ID: 18343890)
1. Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure.
Metzler B; Gfeller P; Wieczorek G; Li J; Nuesslein-Hildesheim B; Katopodis A; Mueller M; Brinkmann V
Int Immunol; 2008 May; 20(5):633-44. PubMed ID: 18343890
[TBL] [Abstract][Full Text] [Related]
2. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
3. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L
Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441
[TBL] [Abstract][Full Text] [Related]
4. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival.
Heng Y; Ma Y; Yin H; Duan L; Xiong P; Xu Y; Feng W; Fang M; Tan Z; Chen Y; Zheng F; Gong F
Transpl Int; 2010 Dec; 23(12):1259-70. PubMed ID: 20536794
[TBL] [Abstract][Full Text] [Related]
6. FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow.
Fujii T; Tomita T; Kanai T; Nemoto Y; Totsuka T; Sakamoto N; Nakamura T; Tsuchiya K; Okamoto R; Watanabe M
Eur J Immunol; 2008 Dec; 38(12):3290-303. PubMed ID: 19009523
[TBL] [Abstract][Full Text] [Related]
7. FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis.
Fujii R; Kanai T; Nemoto Y; Makita S; Oshima S; Okamoto R; Tsuchiya K; Totsuka T; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G267-74. PubMed ID: 16574986
[TBL] [Abstract][Full Text] [Related]
8. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
10. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
[TBL] [Abstract][Full Text] [Related]
11. Chronic alcohol consumption in mice increases the proportion of peripheral memory T cells by homeostatic proliferation.
Zhang H; Meadows GG
J Leukoc Biol; 2005 Nov; 78(5):1070-80. PubMed ID: 16260584
[TBL] [Abstract][Full Text] [Related]
12. Evidence that FTY720 induces rat thymocyte apoptosis.
Isoyama N; Takai K; Tsuchida M; Matsumura M; Naito K
Transpl Immunol; 2006 Apr; 15(4):265-71. PubMed ID: 16635748
[TBL] [Abstract][Full Text] [Related]
13. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
[TBL] [Abstract][Full Text] [Related]
14. Significant prolongation of orthotopic corneal-graft survival in FTY720-treated mice.
Zhang EP; Müller A; Ignatius R; Hoffmann F
Transplantation; 2003 Nov; 76(10):1511-3. PubMed ID: 14657695
[TBL] [Abstract][Full Text] [Related]
15. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
16. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
Kimura T; Hasegawa T; Nakai H; Azuma T; Usui N; Sasaki T; Okada A
Transplantation; 2003 May; 75(9):1469-74. PubMed ID: 12792499
[TBL] [Abstract][Full Text] [Related]
17. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565
[TBL] [Abstract][Full Text] [Related]
18. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Mehling M; Lindberg R; Raulf F; Kuhle J; Hess C; Kappos L; Brinkmann V
Neurology; 2010 Aug; 75(5):403-10. PubMed ID: 20592255
[TBL] [Abstract][Full Text] [Related]
19. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease.
Hashimoto D; Asakura S; Matsuoka K; Sakoda Y; Koyama M; Aoyama K; Tanimoto M; Teshima T
Eur J Immunol; 2007 Jan; 37(1):271-81. PubMed ID: 17154260
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival.
Zhang Q; Chen Y; Fairchild RL; Heeger PS; Valujskikh A
J Immunol; 2006 Jan; 176(2):770-7. PubMed ID: 16393960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
